申请人:JANUS BIOTHERAPEUTICS, INC.
公开号:US20140107115A1
公开(公告)日:2014-04-17
The present invention relates to a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same; and a method for treating or preventing autoimmunity disease using the same.